Aug 5, 2026 - Aug 31, 2026 South Asian Needs Assessment Survey Every journey with inflammatory bowel disease (IBD) is unique, and if you identify as a South Asian person living with IBD, or are supporting a loved one who is, we invite you to share your ... Read MoreEn savoir plus LocationEmplacement • CategoryCatégorie • Research Recherche
Oct 20, 2022 Health Canada has approved SKYRIZI® (risankizumab) an intravenous and subcutaneous medication treatment for adults with moderately to severely active Crohn's Disease Learn moreEn savoir plus
Oct 13, 2022 Send an eCard to Friends or Family Members in Support of Crohn's and Colitis Canada Learn moreEn savoir plus
Sep 30, 2022 Today, September 30, Marks the Second National Day for Truth and Reconciliation in Canada Learn moreEn savoir plus